Skip to main content
SpringerLink
Log in

Effect of nicorandil on abnormal coronary flow reserve assessed by exercise201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms

  • Angina Pectoris
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The purpose of the present study is to assess the effect of nicorandil, a coronary vasodilator with a mechanism of potassium channel opening, on the abnormal myocardial201Tl perfusion evoked by exercise. Eleven patients who had a history of typical angina, positive exercise electrocardiograms, positive201Tl scintigraphy, nearly normal coronary arteriograms, and negative coronary vasospasm underwent exercise201Tl scintigraphies under no medication (baseline test) and administration of nicorandil (nicorandil test).201Tl was injected at a matched workload in both tests. Nicorandil did not alter heart rate, blood pressure, or the rate-pressure product at the end of the exercise, but it significantly improved the extent score from 0.37±0.22 to 0.20±0.15 (p<0.05) and the severity score from 33.9±32.2 to 13.5±16.4 (p<0.05), and also significantly hastened the201Tl mean washout rate from 30.5±14.8% to 37.4±13.1% (p<0.05). Anginal symptoms disappeared in 3 of 5 cases and ST depression improved in 5 of 7 cases after nicorandil. We conclude that nicorandil augments coronary flow reserve, possibly due to a reduction of vasotone in the small coronary arteries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Canon RO, Schenke WH, Leon MB, et al. Limited flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction.Circulation 1987;75:163–174.

    PubMed  Google Scholar 

  2. Legrand V, Hodgson J McB, Bates ER, et al. Abnormal coronary flow reserve in patients with normal coronary angiograms.J Am Coll Cardiol 1985;6:1245–1251.

    PubMed  Google Scholar 

  3. Korhola O, Valle M, Frick MH, et al. Regional myocardial perfusion abnormalities on xenon-133 imaging in patients with angina pectoris and normal coronary arteries.Am J Cardiol 1977;39:355–359.

    PubMed  Google Scholar 

  4. Epstein SE, Canon RO. Site of increased resistance to coronary flow in patients with angina pectoris and normal epicoronary arteries.J Am Coll Cardiol 1986;8:459–461.

    PubMed  Google Scholar 

  5. Maseri A, Crea F, Kaski JC, et al. Mechanism of angina pectoris in syndrome X.J Am Coll Cardiol 1991;17:499–506.

    PubMed  Google Scholar 

  6. Romeo F, Gaspardone A, Ciavolella M, et al. Verapamil versus acebutolol for syndrome X.Am J Cardiol 1988;62:312–313.

    PubMed  Google Scholar 

  7. Cannon RO, Watson RM, Rosing DR, et al. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small vessel coronary artery disease and abnormal vasodilator reserve.Am J Cardiol 1985;56:242–246.

    PubMed  Google Scholar 

  8. Montorsi P, Manfudi M, Loaldi A, et al. Comparison of coronary vasomotor response to nifedipine in syndrome X and Prinzmetal's angina pectoris.Am J Cardiol 1989;63:1198–1202.

    PubMed  Google Scholar 

  9. Burgiardini R, Boghi A, Biagetti L, et al. Comparison of verapamil versus propranolol therapy in syndrome X.Am J Cardiol 1989;63:286–290.

    PubMed  Google Scholar 

  10. Radice M, Giudici V, Albertini A, et al. Usefulness of change in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X.Am Heart J 1994;127:531–535.

    PubMed  Google Scholar 

  11. Galassi A, Kaski JC, Pupita G, et al. Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X.Am J Cardiol 1989;64:264–269.

    PubMed  Google Scholar 

  12. Kinoshita M, Sakai K. Pharmacology and therapeutic of Nicorandil.Cardiovasc Drugs Ther 1990;4:1075–1088.

    PubMed  Google Scholar 

  13. Furukawa K, Itoh T, Kajiwara M, et al. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries.J Pharmacol Exp Ther 1981;218:248–259.

    PubMed  Google Scholar 

  14. Yoneyama F, Satoh K, Taira N. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.Drugs Ther 1990;4:1119–1126.

    PubMed  Google Scholar 

  15. Camici PG, Marraccini P, Lorenzoni R, et al. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: Response to pacing stress.J Am Coll Cardiol 1991;17:1461–1470.

    PubMed  Google Scholar 

  16. Cannon RO, Epstein S. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries.Am J Cardiol 1988;61:1338–1343.

    PubMed  Google Scholar 

  17. Reaven GM. Role of insulin resistance in human disease.Diabetes 1988;37:1595–1607.

    PubMed  Google Scholar 

  18. Dean JD, Jones CJH, Hutchison ST, et al. Hyperinsulinemia and microvascular angina.Lancet 1991;23:456–457.

    Google Scholar 

  19. Ley CJ, Swan J, Godsland IF, et al. Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram.J Am Coll Cardiol 1994;23:377–383.

    PubMed  Google Scholar 

  20. Waldenstrom A, Ronquist G, Lagerqvist B. Angina pectoris with normal coronary angiograms but abnormal thallium perfusion scan exhibit low myocardial and skeletal muscle energy charge.J Int Med 1992;231:327–331.

    Google Scholar 

  21. Canon RO, Bonow RO, Bacharach SL, et al. Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries and abnormal vasodilator reserve.Circulation 1985;71:218–226.

    PubMed  Google Scholar 

  22. Jackson G, Atkinson L, Armstrong P, et al. Angina with normal coronary arteriograms: Value of coronary sinus lactate estimation in diagnosis and treatment.Br Heart J 1978;40:976–978.

    PubMed  Google Scholar 

  23. Opherk D, Zebe H, Weihe E, et al. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms.Circulation 1981;4:817–825.

    Google Scholar 

  24. Crake T, Canepa-Anson R, Shapiro LM, et al. Continuous recording of coronary sinus saturation during atrial pacing in patients with angina pectoris with or without coronary artery disease or with syndrome X.Br Heart J 1987;57:67–72.

    Google Scholar 

  25. Levy RD, Shapiro LM, Wright C, et al. Diurnal variation in left ventricular function: A study of patients with myocardial ischemia, syndrome X, and of normal controls.Br Heart J 1987;57:148–153.

    PubMed  Google Scholar 

  26. Picano E, Lattanzi F, Masini M, et al. Usefulness of a high dose dipyridamole-echocardiography test for diagnosis of syndrome X.Am J Cardiol 1987;60:508–512.

    PubMed  Google Scholar 

  27. Moseri M, Yarom R, Gotsman MS, et al. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries.Circulation 1986;74:964–972.

    PubMed  Google Scholar 

  28. Berger BC, Abramowitz R, Park CH, et al. Abnormal thallium-201 scans in patients with chest pain and angiographically normal coronary arteries.Am J Cardiol 1983;52:365–370.

    PubMed  Google Scholar 

  29. Green LH, Cohn PF, Holman BL, et al. Regional myocardial blood flow in patients with chest pain syndromes and normal coronary arteriograms.Br Heart J 1978;40:242–249.

    PubMed  Google Scholar 

  30. Tweddel AC, Martin W, Hutton I. Thallium scans in syndrome X.Br Heart J 1992;68:48–50.

    PubMed  Google Scholar 

  31. Gassasi AR, Crea F, Arajio LI, et al. Comparison of regional myocardial blood flow in syndrome X and one vessel coronary disease.Am J Cardiol 1993;72:134–139.

    PubMed  Google Scholar 

  32. Epstein SE, Cannon RO, Bonow RO, et al. Exercise testing in patients with microvascular angina.Circulation 1991;83(Suppl III):III73-III76.

    PubMed  Google Scholar 

  33. Sax FL, Cannon RO, Anson C, et al. Impaired forearm vasodilator reserve in patients with microvascular angina: Evidence of a generalized disorder of a vascular function?N Engl J Med 1987;317:1366–1370.

    PubMed  Google Scholar 

  34. Egashira K, Inou T, Hirooka Y, et al. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.N Engl J Med 1993;328:1659–1664.

    PubMed  Google Scholar 

  35. Quyyumi AA, Cannon RO, Panza JA, et al. Endothelial dysfunction in patients with chest pain and normal coronary arteries.Circulation 1992;86:1864–1871.

    PubMed  Google Scholar 

  36. Emdin M, Picano E, Lattanzi F, et al. Improved exercise capacity with acute aminophylline administration in patients with syndrome X.J Am Coll Cardiol 1989;14:1450–1453.

    PubMed  Google Scholar 

  37. Bugiardini R, Pozzati A, Puddu P, et al. Vasotonic angina: A spectrum of ischemic syndromes involving functional abnormalities of the epicardial and microvascular coronary circulation.Am J Coll Cardiol 1993;22:417–425.

    Google Scholar 

  38. Kato K. Hemodynamic and clinical effects of an intravenous potassium channel opener—a review.Eur Heart J 14(Suppl B):40–47, 1993.

    Google Scholar 

  39. Satoh K, Yanagisawa T, Taira N, et al. Effect of 2-nicotinamidethyl nitrate (SG-35) on membrane potentials of canine Purkinje fiber (summary in English).Jpn J Pharmacol 31:409–417, 1981.

    PubMed  Google Scholar 

  40. Yamazaki J, Ohsawa H, Uchi T, et al. Study of the efficacy of nicorandil in patients with ischemic heart disease using exercise201Tl myocardial tomography.Eur J Clin Pharmacol 1993;44:211–217.

    Google Scholar 

  41. Kinoshita M, Nishikawa S, Sawamura M, et al. Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris.Am J Cardiol 1986;58:733–738.

    PubMed  Google Scholar 

  42. Holzmann S. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil.J Cardiovasc Pharmacol 1983;5:364–370.

    PubMed  Google Scholar 

  43. Satoh K, Yamada H, Taira N. Differential antagonism by glibenclamide of the relaxant effects of cromakalim pinacidil and nicorandil on canine large coronary arteries.Naunyn Schmiedebergs Arch Pharmacol 1991;10(Suppl. 8):S17-S24.

    Google Scholar 

  44. Cavero I, Pratz J, Mondot S. K channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.Zeitschrift Kardiol 1991;80(Suppl. 7):35–41.

    Google Scholar 

  45. Berdeaux A, Drieu la Rochelle C, Richard V, et al. Differential effects of nitrovasodilators, potassium channel openers and nicorandil on large and small coronary arteries in consciousness dogs.J Cardiovasc Pharmacol 1985;7:1107–1112.

    PubMed  Google Scholar 

  46. Onishi M, Maeda K, Fukuzaki H. Antianginal mechanism of nicorandil: Study on exercise invasive hemodynamics and thallium-201 myocardial perfusion images (summary in English).Angiology 1987;27:191–195.

    Google Scholar 

  47. Brush JE, Canon RO, Schenke WH, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.N Engl J Med 1988;319:1302–1307.

    PubMed  Google Scholar 

  48. Scheler S, Motz W, Struer BE. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram.Am J Cardiol 1994;73:478–482.

    PubMed  Google Scholar 

  49. Koistinen MJ, Huikuri H, Pirttiaho H, et al. Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients.Br Heart J 1990;63:7–11.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The First Department of Internal Medicine, Kobe University School of Medicine, Kobe, Japan

    Hiroshi Yamabe MD, Hiroyuki Namura, Takashi Yano, Hideki Fujita, Susiku Kim, Masanori Iwahashi, Kazumi Maeda & Mitsuhiro Yokoyama

Authors
  1. Hiroshi Yamabe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Namura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takashi Yano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideki Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susiku Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masanori Iwahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazumi Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mitsuhiro Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamabe, H., Namura, H., Yano, T. et al. Effect of nicorandil on abnormal coronary flow reserve assessed by exercise201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms. Cardiovasc Drug Ther 9, 755–761 (1995). https://doi.org/10.1007/BF00879868

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00879868

Key Words

Search

Navigation